Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-37 Cr₹76 Cr₹19 Cr₹155 Cr₹-93 Cr

What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA is ₹-37 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-37 Cr
Mar2024₹76 Cr
Mar2023₹19 Cr
Mar2022₹155 Cr
Mar2021₹-93 Cr

How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-37 Cr
Negative
Mar2024 ₹76 Cr
290.95
Mar2023 ₹19 Cr
-87.48
Mar2022 ₹155 Cr
Positive
Mar2021 ₹-93 Cr -

Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹104,551.0 Cr 1.7% 8.3% 9.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,593.0 Cr 2% 6.7% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,737.0 Cr 3.5% 2.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,290.0 Cr 4.6% 9.9% 41.5% Stock Analytics
CIPLA ₹117,327.0 Cr -0.3% 3.7% -2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,994.0 Cr 1.1% 5.9% 6.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.7%

8.3%

9.4%

SENSEX

2.2%

5.1%

-7%


You may also like the below Video Courses